Genevant Sciences Company

Genevant Sciences GmbH is a biopharmaceutical company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics enabled by proprietary lipid nanoparticle (LNP) and ligand conjugate delivery technologies. The company's platform has enabled clinical development of the most advanced RNA-based therapeutics.